[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-474577-105":59,"doc-detail-474577-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","strategies-to-address-antimicrobial-resistance-staar-act-section-by-section-summary-antimicrobial-resistance-task-force-section-3","Strategies To Address Antimicrobial Resistance (STAAR) Act - Section-by-Section Summary - Antimicrobial Resistance Task Force (Section 3)","","Section 3 of the STAAR Act expands the Antimicrobial Resistance Task Force to strengthen federal coordination against antimicrobial resistance. It authorizes the Task Force to review related data and issues, issue recommendations domestically and internationally, and update the Public Health Action Plan. It also directs establishment of an Antimicrobial Resistance Office within HHS, creation of a Public Health Antimicrobial Advisory Board, and lays out a strategic research plan, stewardship incentives, CDC education and quality measures, and improved human antimicrobial consumption data collection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/strategies-to-address-antimicrobial-resistance-staar-act-section-by-section-summary-antimicrobial-resistance-task-force-section-3/474577/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/strategies-to-address-antimicrobial-resistance-staar-act-section-by-section-summary-antimicrobial-resistance-task-force-section-3/474577.png","ImageObject",300,407,{"name":92,"@type":93},"sagouaw","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of Section 3 in the STAAR Act?","Question",{"text":112,"@type":113},"Section 3 enhances federal authority and staffing to coordinate a national response to antimicrobial resistance, including periodic updates to the Public Health Action Plan.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Section 3 improve antimicrobial use and stewardship?",{"text":117,"@type":113},"It expands efforts to encourage appropriate antibiotic use, authorizes grants for stewardship program research in healthcare facilities, and directs CDC activities such as education campaigns and antibiotic appropriate-use quality measures.",{"name":119,"@type":110,"acceptedAnswer":120},"What new data collection does Section 3 require?",{"text":121,"@type":113},"It directs CDC to obtain reliable, comparable human antimicrobial drug consumption data and also to collect data on antimicrobial resistance patterns and antimicrobial use.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},474577,1793115070,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":4},3985747862151,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Strategies To Address Antimicrobial Resistance (STAAR) Act  \nSection-by-Section Summary  \nSECTION 3. ANTIMICROBIAL RESISTANCE TASK FORCE  \nCongress established the interagency Antimicrobial Resistance Task Force in 1999, but authorization for the Task Force (Sec 319E, PHSA) expired in 2006. Created to coordinate federal efforts to combat antimicrobial resistance, the Task Force quickly developed the Public Health Action Plan to Combat Antimicrobial Resistance. Implementation of the plan, however, was not optimal because the Task Force had little authority or funding. There were no personnel dedicated to executing the plan; Task Force members all had full-time responsibilities in the various federal health agencies participating on the Task Force.  \nOrganization  \nSection 3 builds on the work of the Antimicrobial Resistance Task Force by enhancing authority, and personnel to execute a coordinated federal response to antimicrobial resistance. The STAAR Act reauthorizes the Task Force to review all data and issues related to antimicrobial resistance, make recommendations on how to combat resistance in the United States and internationally, and integrate these efforts through periodic updates to the Public Health Action Plan to Combat Antimicrobial Resistance. Section 3 directs the Assistant Secretary of Health to establish an Antimicrobial Resistance Office in the Department of Health and Human Services to facilitate coordination, planning and implementation of efforts across federal agencies and departments. And because antimicrobial resistance critical expertise exists outside of the federal government, a Public Health Antimicrobial Advisory Board is created to allow experts from domestic and international health communities to contribute to the effort.  \nStrategic Research Plan on Antimicrobial Resistance  \nThe National Institutes of Health (NIH) is directed to work with other agencies and a blue-ribbon panel of experts to create a strategic research plan for antimicrobial resistance similar to what NIH has created for HIV/AIDS, Tuberculosis, and biodefense. The research plan should provide a detailed path forward for future funding of epidemiological, interventional, clinical, behavioral, translational, and basic research efforts.  \nAppropriate Use/Quality Measures  \nSection 3 also expands efforts to encourage appropriate use of antibiotics (a critical mechanism for preventing the development of resistance) . Section 3 authorizes grants to healthcare facilities to study the development and implementation of antimicrobial stewardship programs, and directs additional Centers for Disease Control and Prevention (CDC) activities, including: conducting an educational campaign on antibiotic use, piloting and testing antibiotic appropriate use quality measures, and developing methods to help health care providers and facilities improve appropriate antibiotic use.  \nHuman Antimicrobial Data  \n There is a significant shortcoming in the United States regarding the collection and dissemination of data on the amount of antimicrobial products used in humans. In contrast, such drug consumption data is collected in Europe and made available to experts. This provision directs CDC to work with private vendors, health care organizations, pharmacy benefit managersand other entities to obtain reliable and comparable human antimicrobial drug consumption data.  \nStrategies To Address Antimicrobial Resistance (STAAR) Act  \nSection-by-Section Summary  \nIn addition, Section 3 also directs CDC to collect data on antimicrobial resistance patterns and antimicrobial use. Section 3 also directs the Office of the National Coordinator for Health Information Technology to work with CDC to determine how best antimicrobial use, susceptibility, and resistance data can be incorporated into meaningful use reporting.  \nLastly, Section 3 calls upon CDC to issue a report every two years that will outline the major issues in resistance; provide data on the societal bu","cbCairB8L4dROTvY","https://ap.wps.com/l/cbCairB8L4dROTvY","pdf",17030,"English","# Section 3. Antimicrobial Resistance Task Force\n## Organization and authority expansion\n## Strategic research plan\n## Appropriate use and quality measures\n## Human antimicrobial data","[{\"question\":\"What is the purpose of Section 3 in the STAAR Act?\",\"answer\":\"Section 3 enhances federal authority and staffing to coordinate a national response to antimicrobial resistance, including periodic updates to the Public Health Action Plan.\"},{\"question\":\"How does Section 3 improve antimicrobial use and stewardship?\",\"answer\":\"It expands efforts to encourage appropriate antibiotic use, authorizes grants for stewardship program research in healthcare facilities, and directs CDC activities such as education campaigns and antibiotic appropriate-use quality measures.\"},{\"question\":\"What new data collection does Section 3 require?\",\"answer\":\"It directs CDC to obtain reliable, comparable human antimicrobial drug consumption data and also to collect data on antimicrobial resistance patterns and antimicrobial use.\"}]","Strategies To Address Antimicrobial Resistance (STAAR) Act - Section-by-Section Summary - Antimicrobial Resistance Task Force (Section 3) | PDF",1790784423]